We are a globally founded healthcare company with headquarters outside of Copenhagen, Denmark. Our US headquarters is based in Plainsboro, New Jersey.
For more than 100 years, we have been
driving change to defeat diabetes. This has given us the expertise and
capabilities to help defeat other serious chronic diseases, including
obesity, rare diseases, and cardiovascular conditions.
From our labs to our factory floors, we are discovering and developing
innovative biological medicines and making them accessible and
affordable to patients throughout the world.
Today, we treat over 10 million US
patients and have more than 20 medicines helping people across 4
therapeutic areas.
Founded by the Novo Nordisk Foundation, we have a responsibility to the people we serve and the communities and environments that we work in. We believe in driving our business through sustainable, conscious and responsible practices that bring value to society. Every day we strive to maintain a healthy planet, guided by our ambition to achieve zero environmental impact.
Access and affordability are also of paramount importance. We share
the joint responsibility to make our medicines both accessible and
affordable. Our NovoCare Affordability Program has helped over 1
million US patients afford their medicines.
See
where we stand on issues related to affordability and access.
The Novo Nordisk Way describes the values and behaviors that guide everything we do. It is rooted in the principles and vision of our founders who set out on an ambitious journey to drive change for patients with diabetes in 1923.
Today, we are thousands of colleagues applying the same passion, skills, and commitment to our purpose of driving change to defeat serious chronic diseases, built upon our heritage in diabetes.
Our key values of openness, accountability, and respect underpin our work to drive change for a healthier world. To help us live these values, 10 Essentials guide the decisions and actions of every Novo Nordisk colleague. We:
- Create value by having a patient-centered business approach.
- Set ambitious goals and are empowered to achieve them.
- Hold ourselves accountable for our financial, environmental, and social performance.
- Remain curious and innovate for the benefit of patients and society at large.
- Build and maintain good relations with our stakeholders.
- Value inclusiveness and diversity and treat everyone with respect.
- Focus on performance and personal development.
- Foster a healthy and engaging working environment.
- Strive for agility and simplicity in everything we do.
- Choose to never compromise on quality and ethics.
As a life sciences employer focused on treating a diverse array of
patients, our employee populations must reflect the diversity of the
communities we serve. That's why we have a responsibility to make
Diversity, Equity, Inclusion & Belonging (DEI&B) part of
everything we do—from developing our products to building and
supporting our workforce.
Learn
how we bring this approach to life through our culture.
We believe it takes more than medicine to drive change in the lives of patients with serious chronic conditions.
By coupling a deep disease understanding with empathy, we’re always innovating so we can provide more solutions in the future.
Learn how we are transforming care through science across our key therapeutic areas:
- Cardiovascular Disease
- Diabetes
- Obesity
- Rare Diseases
In 1923, our Danish founders began a journey to drive change for
patients with diabetes through the creation of insulin. After 100
years, our mission has expanded, but our goal of improving the lives
of our patients has not.
Read about
our history of innovation and philanthrophy.
Our US headquarters plays a critical role in the vibrancy of the life sciences industry. Here we are responsible for sales, marketing and clinical trials management for all Novo Nordisk US products.
Our Cell Therapy R&D spans the full value chain of drug
discovery, from early research to clinical development. This site is
focused on innovation in stem cell-based replacement therapies.
Download
our California location fact sheet.
Our manufacturing and research facility for RNAi therapeutics. This site specializes in operations and chemistry manufacturing and controls (CMC) for oligonucleotides and RNAi therapeutics.
This site expands our manufacturing capacity to meet current and future demand for our rare and chronic disease products. Operators and technicians work various shifts around-the-clock depending on facility and production needs.
Our greater Boston R&D hub, located in Lexington, Watertown and Cambridge, brings together the best minds in life science innovation. Here, we are building for the future, creating a distinct R&D community based on collaboration, partnerships, and cutting-edge research.
For more than 30 years, North Carolina has been home to Novo Nordisk’s first and largest manufacturing presence in the US. With a facility located in Durham, two additional sites in Clayton, and currently undergoing a $4.1 billion expansion, our teams operate continuously to produce diabetes and obesity medications serving millions of patients.
Our West Lebanon, New Hampshire site is a life-science production facility focused on continuous manufacturing to deliver products for rare bleeding disorders and growth disorders.
Our newly acquired manufacturing facility in Petersburg is focused on increasing development and production of future Novo Nordisk products.
